Skip to main content

HealthLynked Corp

corporate_fare Company Profile

HealthLynked Corp

HLYK·OTC·Industrial Applications And Services·CIK 0001680139

HealthLynked Corp. is a healthcare technology company incorporated in Nevada on August 6, 2014. The company operates across three primary divisions: Digital Healthcare, Health Services, and Medical Distribution. Its key objectives are to improve patient care management, enhance the operational efficiency of medical practices, and utilize healthcare data to gain unique insights into diseases. Within the Digital Healthcare division, HealthLynked develops and manages the HealthLynked Network, a cloud-based platform that centralizes personal medical records and streamlines communication between patients and healthcare providers. This platform integrates software-based decision-support tools, including AI-enabled features, on-demand telemedicine services, and concierge support. The AI-enabled features support patient engagement and care navigation and are not intended to provide medical diagnoses, treatment recommendations, or replace the judgment of licensed healthcare professionals. Historically, the Health Services division operated and managed various clinical medical practices, including women's health services, physical therapy, aesthetic services, primary care, and functional medicine. These operations supported the development of the digital healthcare platform by providing real-world testing environments and generating patient and provider feedback. As the technology platform matured, the company reduced its exposure to direct clinical operations and exited or divested non-core practices. Currently, it operates a single clinical service focused on functional medicine.

HealthLynked Corp (OTC:HLYK) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 8 items for HLYK at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-14, rated 9/10. Across its 8 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for HLYK spans 10-Q, 8-K, S-1/A, 10-K.

Recent high-impact activity:

  • HealthLynked Reports Deepening Losses, Critical Cash Shortage, and Persistent Going Concern Warning
  • HealthLynked Names George O'Leary Interim CFO, Eliminates COO Role Amid Nasdaq Uplisting Push
  • HealthLynked Files S-1 for $7M Public Offering at Significant Premium, Pursues Nasdaq Listing
  • HealthLynked Corp. Reports Worsening Financials, Persistent Going Concern, and Ineffective Controls
  • HealthLynked Files S-1 for $7M Offering and Nasdaq Uplisting to Address Going Concern

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.07M
Net Income
-$3.28M
Diluted EPS
-$1.16
Op. Cash Flow
-$1.71M
Operating Income
-$2.11M
Cash & Equivalents
$37.14K
Debt / Equity
0.00×
Net Margin
-158.8%
Shares Outstanding
2.82M sh
Source: 10-K · filed 2026-03-31 · accession 0001213900-26-037499

Short Interest & Short Volume

On October 2, 2026, 55.5% of HLYK volume reported to FINRA trade-reporting facilities was marked short.

Daily short volume (FINRA facilities)55.5% of 2,086 shares on October 2, 2026
3-day average short volume56.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for HLYK, detected from its recent SEC filings · based on capital-structure filings through 2026-05-29.

2 shelf registrations

Public Offering Details · Nasdaq Listing Contingency

⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with H →
$2.3 -0.02% today
52-week range · as of 2026-08-14 $1.06 – $6.5
Market cap
$6.79M
Volume
2.1K (1.7× avg)
3-mo avg 1.3K
Live data · 2026-10-05 04:26 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed HLYK - Latest Insights

HLYK
Aug 14, 2026, 4:57 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.75
Real-time Price: $2.30 info
Change: -$0.450 (-16%) info
Market Cap: $6.792M info
HLYK
Jul 16, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.95
Real-time Price: $2.30 info
Change: -$0.650 (-22%) info
Market Cap: $6.792M info
HLYK
May 29, 2026, 4:39 PM EDT
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $2.28
Real-time Price: $2.30 info
Change: +$0.017 (+0.74%) info
Market Cap: $6.792M info
HLYK
May 15, 2026, 3:00 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.06
Real-time Price: $2.30 info
Change: +$0.239 (+12%) info
Market Cap: $6.792M info
HLYK
Apr 30, 2026, 4:33 PM EDT
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $2.62
Real-time Price: $2.30 info
Change: -$0.320 (-12%) info
Market Cap: $6.792M info
HLYK
Mar 31, 2026, 4:30 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $3.25
Real-time Price: $2.30 info
Change: -$0.949 (-29%) info
Market Cap: $6.792M info
HLYK
Feb 09, 2026, 7:29 PM EST
Filing Type: S-1
Importance Score:
9
Price at Filing: $3.43
Real-time Price: $2.30 info
Change: -$1.13 (-33%) info
Market Cap: $6.792M info
HLYK
Feb 06, 2026, 4:00 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.10
Real-time Price: $2.30 info
Change: -$0.800 (-26%) info
Market Cap: $6.792M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets